VAERS reports by lot

Merck HPV lot H014645: VAERS reports

32 VAERS reports list lot H014645 as a Merck HPV vaccine, received between 2012-11-09 and 2020-09-24. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
32
Reports
31%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Neurological3930%
General / Systemic (non-local)2620%
Gastrointestinal1512%
Cardiac / Cardiovascular108%
Dermatological (non-injection-site)97%
Musculoskeletal75%
Psychiatric / Neuropsychiatric75%
Autoimmune / Immune-mediated54%
Allergic / Anaphylactic54%
Injection-site / Local reaction54%
Thrombotic / Hematological11%
Respiratory11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California6
Colorado5
Arizona3
Pennsylvania2
Hawaii1
Iowa1
Massachusetts1
Florida1
New York1
Wisconsin1
Idaho1
North Dakota1

Reports by month received

2012-112
2012-122
2013-014
2013-024
2013-034
2013-042
2013-051
2013-068
2013-071
2013-091
2013-121
2014-011
2020-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.